News

Home/News
News 2018-08-09T15:32:37+00:00
June 6, 2018
Avenue Therapeutics to Host Key Opinion Leader Call on Intravenous (IV) Tramadol for the Management of Postoperative Pain
NEW YORK, June 06, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (ATXI) (“Avenue”), a company focused on the development and commercialization of intravenous (IV) tramadol, ...
June 5, 2018
Opiant Pharmaceuticals to Participate in Opioid Panel at the BIO International Convention
SANTA MONICA, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced ...
June 5, 2018
Molecular Templates Presents Clinical Data at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018
AUSTIN, Texas, June 04, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (MTEM), a clinical stage biopharmaceutical company focused on the discovery and development of Engineered ...
June 5, 2018
Kiadis Pharma announces results of Annual General Meeting
Amsterdam, The Netherlands, June 5, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company ...
June 5, 2018
Basilea reports presentation of phase 1 clinical data with anticancer drug candidate BAL101553 at ASCO meeting
Basel, Switzerland, June 05, 2018 - Basilea Pharmaceutica Ltd. (SIX:BSLN) reported today that data from the phase 1 dose-escalation parts of two phase 1/2a studies ...
June 5, 2018
AgeX Therapeutics Appoints John F. Mauldin to Board of Directors
ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. (NYSE American: BTX) focused on prolonging healthspan through an understanding of the fundamental mechanisms of human ...
June 5, 2018
InflaRx Opens New Research Facility in Ann Arbor
JENA, Germany, June 05, 2018 (GLOBE NEWSWIRE) -- InflaRx N.V. (IFRX), a biopharmaceutical company developing innovative therapeutics to treat life-threatening inflammatory diseases by targeting the ...
June 5, 2018
UroGen Pharma Announces Stephen Mullennix as Interim Chief Financial Officer and Jason Patel as Vice President of Finance
RA’ANANA, Israel, and NEW YORK, June 05, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
June 5, 2018
PolarityTE Announces Pricing of Public Follow-on Offering of Common Stock
SALT LAKE CITY, June 05, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of ...
June 4, 2018
Sensorion’s Chair of Scientific Advisory Board, Prof. Christine Petit, Awarded 2018 Kavli Prize in Neuroscience
MONTPELLIER, France--(BUSINESS WIRE)-- Regulatory News: Sensorion (FR0012596468 – ALSEN) (ALSEN.PA), a biotech company specializing in the treatment of inner ear diseases today announced that Prof. Christine Petit, ...
June 4, 2018
Results of Kamada’s Phase 2 Trial of Alpha-1 Antitrypsin in Newly Diagnosed Type-1 Diabetes Patients to be Presented at the Upcoming American Diabetes Association’s 78th Scientific Sessions
REHOVOT, Israel, June 04, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (KMDA) (KMDA.TA), a plasma-derived protein therapeutics company, today announced that the results from the Company’s ...
June 4, 2018
ProQR Announces Presentations at ECFS on Eluforsen for F508del Cystic Fibrosis and at CFF Research Conference
LEIDEN, The Netherlands, June 04, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (PRQR), a company dedicated to changing lives through the creation of transformative RNA ...
June 4, 2018
Stelis Biopharma and Oncobiologics to Unveil Bio2Source CDMO Offering at BIO 2018
CRANBURY, N.J., June 04, 2018 (GLOBE NEWSWIRE) -- Stelis Biopharma and Oncobiologics, Inc. (ONS) today announced that they will unveil a new contract development and ...
June 4, 2018
NexoBrid® Receives Marketing Authorization From South Korea’s Ministry of Health
YAVNE, Israel, June 04, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
June 4, 2018
Aptose Announces Two Publications of Preclinical Data Elucidating the Anticancer Mechanism of Action of APTO-253
SAN DIEGO and TORONTO, June 04, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (APTO) (APS.TO) today announced the publication of preclinical data elucidating the mechanism ...
June 4, 2018
Palatin Technologies Announces FDA Acceptance for Review of Bremelanotide NDA
CRANBURY, N.J., June 4, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases ...
June 4, 2018
CytoSorbents to Present at the Jefferies 2018 Global Healthcare Conference
MONMOUTH JUNCTION, N.J., June 4, 2018 /PRNewswire/ -- CytoSorbents Corporation(CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in ...
June 4, 2018
Miragen Therapeutics to Present First Cobomarsen Phase 1 Clinical Trial Data From Patients With Adult T-Cell Leukemia/lymphoma and New Interim Data From Patients With Mycosis Fungoides at the 2018 American Society of Clinical Oncology Annual Meeting
BOULDER, Colo., June 04, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, ...
June 4, 2018
Reata Announces That Kyowa Hakko Kirin Initiated Ayame, a Phase 3 Trial of Bardoxolone Methyl for the Treatment of Diabetic Kidney Disease
IRVING, Texas, June 04, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA), a clinical-stage biopharmaceutical company, today announced that its licensee, Kyowa Hakko Kirin Co., ...
June 4, 2018
Soleno Therapeutics To Present Corporate Update at the BIO International Convention
REDWOOD CITY, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of ...
Page 13 of 95